Stock-Based Compensation (Tables)
|
12 Months Ended |
Dec. 31, 2025 |
| Stock-Based Compensation |
|
| Schedule of assumptions used to estimate the fair value of stock options |
| | Year Ended December 31, | | | | 2025 | | | 2024 | | Weighted-average fair value of options granted | | $ | 3.62 | | | $ | 3.64 | | Expected volatility | | | 70 | % | | | 75 | % | Expected life (in years) | | | 5.78 | | | | 5.69 | | Risk-free interest rate | | | 4.43 | % | | | 4.13 | % | Expected dividend yield | | | 0.00 | % | | | 0.00 | % |
|
| Schedule of stock option activity |
| | Number of Shares | | | Weighted-Average Exercise Price | | | Weighted-Average Remaining Contract Life | | Aggregate Intrinsic Value (in thousands) | | Outstanding at January 1, 2024 | | | 7,995,799 | | | | 2.73 | | | 5.3 years | | | 3,362 | | Granted | | | 328,500 | | | | 1.88 | | | | | | | | Exercised | | | (1,460,404 | ) | | | 1.32 | | | | | | | | Cancelled/forfeited | | | (201,096 | ) | | | 3.04 | | | | | | | | Outstanding at December 31, 2024 | | | 6,662,799 | | | | 2.64 | | | 4.9 years | | | 19,469 | | Granted | | | 405,500 | | | | 5.72 | | | | | | | | Exercised | | | (3,270,703 | ) | | | 1.57 | | | | | | | | Cancelled/forfeited | | | (143,098 | ) | | | 5.00 | | | | | | | | Outstanding at December 31, 2025 | | | 3,654,498 | | | | 4.38 | | | 4.4 years | | | 7,707 | | Shares vested and expected to vest | | | 3,603,664 | | | | 4.37 | | | 5.3 years | | | 7,503 | | Exercisable as of December 31, 2025 | | | 3,269,982 | | | | 4.30 | | | 3.8 years | | | 7,170 | | Exercisable as of December 31, 2024 | | | 5,866,379 | | | | 2.89 | | | 3.8 years | | | 14,950 | |
|
| Summary of RSUs outstanding |
| | Years Ended December 31, | | | | 2026 | | | 2027 | | | 2028 | | RSUs with service-based vesting conditions | | | 225 | | | | 165 | | | | 37 | |
|
| Summary of RSUs activity |
| | Number of Units | | | Weighted-Average Fair Value | | Outstanding at January 1, 2024 | | | 13,334 | | | $ | 1.73 | | Granted | | | 440,000 | | | | 5.24 | | Vested/released | | | (109,166 | ) | | | 5.05 | | Cancelled/forfeited | | | (38,334 | ) | | | 4.73 | | Outstanding at December 31, 2024 | | | 305,834 | | | | 5.21 | | Granted | | | 395,000 | | | | 5.87 | | Vested/released | | | (228,321 | ) | | | 5.48 | | Cancelled/forfeited | | | (7,500 | ) | | | 5.36 | | Outstanding at December 31, 2025 | | | 465,013 | | | | 5.64 | |
|
| Schedule of statement of operations effect of stock-based compensation |
| | Year Ended December 31, | | | | 2025 | | | 2024 | | Share-based compensation expense by type: | | | | | | | Stock options | | $ | 1,633 | | | $ | 2,399 | | Restricted stock units | | | 1,299 | | | | 603 | | Total cost related to share-based compensation expense | | $ | 2,932 | | | $ | 3,002 | | Share-based compensation expense by financial statement line item: | | | | | | | | | Cost of revenue | | $ | 358 | | | $ | 476 | | Research and development | | | 474 | | | | 611 | | Selling and marketing | | | 440 | | | | 548 | | General and administrative | | | 1,660 | | | | 1,367 | | Total cost related to share-based compensation expense | | $ | 2,932 | | | $ | 3,002 | |
|